InvestorsHub Logo
Followers 0
Posts 70
Boards Moderated 0
Alias Born 02/29/2016

Re: jsmith123343 post# 57772

Tuesday, 03/29/2016 5:39:20 PM

Tuesday, March 29, 2016 5:39:20 PM

Post# of 463629
the rejection was for 2-73 PLUS -

This invention concerns a dosage form comprising a therapeutically neuroprotective amount of A2-73 and a neuroprotective amount of at least one cooperating acetylcholinesterase inhibitor selected from the group consisting of donepezil, galantamine, rivastigmine, or memantine and method of use.

Does anyone have the application patent ID for 2-73 itself ?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News